What is NDC 70756-315?

70756-315 is the product NDC for telmisartan and hydrochlorothiazide, Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, listed with the FDA by Lifestar Pharma LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

What is the active ingredient?

Telmisartan, Hydrochlorothiazide.

Lifestar Pharma LLC, NDC labeler code 70756. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for telmisartan and hydrochlorothiazide?

23 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

telmisartan and hydrochlorothiazide NDC 70756-315

NDC codes

FDA NDC Directory

Product NDC (as listed)70756-315Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70756-0315Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70756-315-30	70756031530	30 TABLET in 1 BOTTLE (70756-315-30)Marketed from Dec 25, 2025
70756-315-31	70756031531	3 BLISTER PACK in 1 CARTON (70756-315-31) / 10 TABLET in 1 BLISTER PACKMarketed from Dec 25, 2025
70756-315-99	70756031599	10 BLISTER PACK in 1 CARTON (70756-315-99) / 10 TABLET in 1 BLISTER PACKMarketed from Dec 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): telmisartan and hydrochlorothiazide
Generic name (nonproprietary): telmisartan and hydrochlorothiazide
Active ingredients: Telmisartan — 40 mg/1Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Lifestar Pharma LLCNDC labeler code 70756
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218406
Marketing start: Dec 25, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 70756-315_70efda7e-0c71-4faf-be4e-ef281d7cc297SPL ID 70efda7e-0c71-4faf-be4e-ef281d7cc297SPL set ID 0c1bd0f4-034e-486c-ae46-2855c8c9ebdaRxCUI 283316, 283317, 477130UNII 0J48LPH2TH, U5SYW473RQUPC 0370756315018, 0370756316015, 0370756317319, 0370756317012, 0370756315315
Pharmacologic class: Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470756031530 followed by a unit qualifier and the quantity

Package 70756-0315-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 20, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the classes to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with telmisartan and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70756-315

What is NDC 70756-315?: 70756-315 is the product NDC for telmisartan and hydrochlorothiazide, Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, listed with the FDA by Lifestar Pharma LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: telmisartan and hydrochlorothiazide.
What is the active ingredient?: Telmisartan, Hydrochlorothiazide.
Who is the labeler?: Lifestar Pharma LLC, NDC labeler code 70756. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for telmisartan and hydrochlorothiazide?: 23 other product NDCs are listed under this name. See all telmisartan and hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other telmisartan and hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
telmisartan and hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Lifestar Pharma LLC	70756-316	70756-0316-3070756-0316-3170756-0316-99
telmisartan and hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Lifestar Pharma LLC	70756-317	70756-0317-3070756-0317-3170756-0317-99
Telmisartan and Hydrochlorothiazide	Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	AvKARE	42291-462	42291-0462-30
Telmisartan and Hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	AvKARE	42291-463	42291-0463-30
Telmisartan and Hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	AvKARE	42291-464	42291-0464-30
Telmisartan and Hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-841	68462-0841-13
Telmisartan and Hydrochlorothiazide	Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-840	68462-0840-13
Telmisartan and Hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-842	68462-0842-13
Telmisartan And Hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Solco Healthcare LLC	43547-442	43547-0442-0343547-0442-09
Telmisartan And Hydrochlorothiazide	Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Solco Healthcare LLC	43547-441	43547-0441-0343547-0441-09

All 24 telmisartan and hydrochlorothiazide NDCs

Other NDCs under ANDA 218406

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218406
Product	Strength	Form · route	Labeler	Product NDC
telmisartan and hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Lifestar Pharma LLC	70756-316
telmisartan and hydrochlorothiazide	Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Lifestar Pharma LLC	70756-317